Epizyme (EPZM) Tops Q1 EPS by 12c
Tweet
Share
E-mailGet Alerts EPZM Hot Sheet
Join SI Premium – FREE
Epizyme (NASDAQ: EPZM) reported Q1 EPS of ($0.41), $0.12 better than the analyst estimate of ($0.53). Revenue for the quarter came in at $472 thousand versus the consensus estimate of $900 thousand.
For earnings history and earnings-related data on Epizyme (EPZM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Calamp Corp. (CAMP) Misses Q2 EPS by 33c
- Marpai, Inc. (MRAI) Misses Q2 EPS by 18c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
